These considerations are taken into account in the CPS expressing PD-L1 positivity of cancer microenvironment as a ratio of the number of all PD-L1 positive cells (including lymphocytes, macrophages, and tumor cells) divided by the total number of tumor cells [63]. The gene discussed is CD274; the disease is neoplasm.